A new study reveals the recently recalled Medtronic Heartware HVAD system has more than double the risk of causing neurological adverse events in patients than the Abbott Heartmate3, which is…
Abbott is warning of power loss problems with its HeartMate 3 implants, which could lead to serious injuries or even death.
About 29,000 HeartMate II LVAS pocket controllers are subject of an FDA recall warning following the death of 26 patients who tried changing the controller improperly or too slowly.
The FDA is warning of serious adverse event risks tied to two heart implants, the HeartMate II and the Heartware HVAD, which could cause bleeding, strokes, and blood clot problems.
A new study suggests that heart implants like the HeartMate II may cause a decline in mental functioning and memory in older patients.
The FDA says that a Thoratec warning regarding the pocket controller for its HeartMate II LVAS should be considered a class I recall following reports of deaths and serious injuries.
A new study highlights how some risk factors may affect whether individuals experience complications with Thoratec HeartMate II performance.
Thoratec announced that four patients had died trying to switch controllers for a new HeartMate II LVAS Pocket Controller, and advised patients to get updated training on the new models.
A new class action lawsuit claims Thoratec lied to investors about the safety of its HeartMate II implants.
Thoratec officials say a recent study warning of HeartMate II blood clots does not give the full picture.
